# Role of Triptorelin 0.1 mg as a Luteal Phase Support in Assisted Reproductive Technique After Embryo Transfer : a Randomized Controlled Trial

> **NCT04087408** · PHASE3 · UNKNOWN · sponsor: **Moustafa Mohammed Abouelea** · enrollment: 150 (estimated)

## Conditions studied

- Effect of Adding GnRHa as Luteal Phase Support in Antagonist ART Cycles

## Interventions

- **DRUG:** Effect of adding gonadotropins releasing hormone agonist to progesterone for luteal phase support in assisted reproductive technique )antagonist cycles(: a randomized controlled trial

## Key facts

- **NCT ID:** NCT04087408
- **Lead sponsor:** Moustafa Mohammed Abouelea
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-01
- **Primary completion:** 2022-07-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04087408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04087408, "Role of Triptorelin 0.1 mg as a Luteal Phase Support in Assisted Reproductive Technique After Embryo Transfer : a Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04087408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*